MedTech Innovator Announces Finalists for US$250K+ Annual Asia Pacific Competition
MedTech Innovator Announces Finalists for US$250K+ Annual Asia Pacific Competition
Five companies to compete in Grand Finals hosted by MedTech Innovator in partnership with APACMed
LOS ANGELES and SINGAPORE, Monday, 26 October, 2020 – MedTech Innovator, the largest accelerator of medical devices in the world, in partnership with Asia Pacific Medical Technology Association (APACMed), the first and only regional association to provide a unified voice for the medical technology industry, today announced that Cartosense, Healthy Networks, Remidio, Sporogenics, and X-Zell have been selected as finalists to compete for the title of the 2020 Asia Pacific Grand Prize winner, out of more than 170 applicants. Attendees of the competition finals will virtually vote for the Grand Prize of US$150,000 which will be presented along with over US$100,000 in additional awards on November 18 during a joint event hosted by MedTech Innovator in partnership with APACMed.
“This year’s group of finalist companies are working to address some of the most critical health issues in the Asia Pacific region,” said Paul Grand, CEO of MedTech Innovator. “Now in its second year, the MedTech Innovator Asia Pacific program features the best of the best in health innovation. All of the companies that participated in this year’s program have demonstrated promise and a clear commitment to improving the lives of patients in the Asia Pacific region and beyond. We look forward to seeing each finalist company present and anticipate a very tough competition.”
“We are delighted to be partnering with MedTech Innovator for the second year,” said Harjit Gill, Chief Executive Officer, APACMed. “The number of startups going through the program continues to grow, and this is essential to drive innovation in the region.”
The five finalist companies are developing transformative medical technology innovations in the areas of neurology, pulmonology, ophthalmology, and oncology.
- Cartosense is developing a portable, affordable, and highly flexible surgical navigation for neurosurgery. The company is based in Chennai, India.
- Healthy Networks is developing the world’s most affordable smart stethoscope for lungs — detecting disease early to save lives. The company is based in Talinn, Estonia.
- Remidio is developing an FDA 510k exempted, patented, non-mydriatic, smartphone-based portable retinal imaging device. The company is based in Bengaluru, India.
- Sporogenics is developing a biodegradable implantable device for postsurgical anti-adhesion and anti-carcinomatosis application. The company is based in Singapore.
- X-Zell is developing an accurate, affordable, and globally scalable early cancer detection from a small, 10mL blood samples. The company is based in Singapore.
During the competition finals on Wednesday, November 18 each of the five companies will have seven minutes to pitch their technology and answer questions before a virtual panel of five judges. After the presentations, the online live audience will vote in real-time to select the winners. The first-place startup will take home a US$150,000 non-dilutive cash prize. The other four finalists will each receive a US$10,000 cash prize. There will also be a SG$30,000 non-dilutive grant and an invitation to join the qualifying round at the SLINGSHOT competition in Singapore awarded by Enterprise Singapore. Other prizes include a one-year residency awarded by JLABS @ Shanghai and the Oliver Healthcare Packaging Sterile Barrier System Design & Development Award. Please visit this page to register for a link to watch the competition November 18 livestream.
Judges include Kiyoshi Miyake, Senior Expert, Technology Scouting and Collaboration, Office of CTO, Olympus; Peter Hawkes, Head of Business Development, Asia Pacific, Johnson & Johnson; Julie Tay, Senior Vice President and Managing Director, Asia Pacific, Align Technology; Florian Belohlavek, Head of Strategy, Marketing and Sales, Asia Pacific, Siemens Healthineers; Tomoko Ishikura, Business Development Advisor, Nipro Corporation.
Together with the senior leadership teams of its corporate partners and other judges, MedTech Innovator evaluated more than 170 applications for its Asia Pacific program this year and selected 35 candidates to advance for virtual meetings via Zoom. 20 companies were then selected to participate in the Asia Pacific Accelerator program, which prominently features the most innovative medtech startups from the region.
MedTech Innovator’s 2020 Asia Pacific program sponsors include Johnson & Johnson Medical Devices Companies, Align Technology, Nipro Medical Corporation, Oliver Healthcare Packaging, Olympus Medical Systems Group, Siemens Healthineers, and Enterprise Singapore. The MedTech Innovator Asia Pacific Program is held in partnership with APACMed.
About APACMed
The Asia Pacific Medical Technology Association (APACMed) represents manufacturers and suppliers of medical equipment, devices and in-vitro diagnostics, industry associations and other key stakeholders associated with the medical technology industry in Asia Pacific. Our mission is to improve the standards of care for patients through innovative collaborations among stakeholders to jointly shape the future of healthcare in Asia Pacific. Learn more about the association at: https://apacmed.org/
About MedTech Innovator
Based in Los Angeles, Calif., MedTech Innovator is the largest accelerator of medical device companies in the world and the premier nonprofit startup accelerator in the medical technology industry.[i] Its mission is to improve the lives of patients by accelerating the growth of companies that are transforming the healthcare system. MedTech Innovator matches healthcare industry leaders with innovative early-stage and emerging growth medtech companies for mentorship and support.
For more information about MedTech Innovator, visit MedTech Innovator and follow @MedTechAwards on Twitter. To receive industry insights and highlights about MedTech Innovator’s current and alumni participant companies, subscribe to its monthly newsletter.
Media Contact:
Lara Lingenbrink
Health+Commerce
858.525.1414
[i] Gibbs, M., Johnson, B., Silva, B. A., & Berube, K. (2020, July 10). Q2 2020 Life Science Accelerators Insights Cipher Bio. Retrieved September 15, 2020, from https://www.cipherbio.com/blog/life-science-accelerators-insights/
